• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Cancer Detection Test Fails in Major Study

The New York Times – Business:

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Cancer, Clinical Trials, DNA (Deoxyribonucleic Acid), Food and Drug Administration, Grail Inc, Health Insurance and Managed Care, Regulation and Deregulation of Industry, Research, Tests (Medical)
←Opendoor rises as JPMorgan boosts earnings estimates following Q4 results
Nvidia nears $30 billion investment in OpenAI’s funding round, the FT reports→

More posts

  • Andy Cohen Calls ‘Summer House’ Season 10 Reunion “Intense” Amid Amanda Batula & West Wilson’s Betrayal Of Ciara Miller: “This Was A Lot”

  • Mike Vrabel Speaks On Dianna Russini Scandal Before NFL Draft

  • Erin Moriarty Filmed One Of Her “Most Important Episodes” Of ‘The Boys’ During “Peak” Health Issues: “F*ck Autoimmune Disease”

  • Warren draws ‘parallels’ between AI ‘bubble’ and financial crisis

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube